Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Combined oral therapy with sildenafil and doxazosin for the treament of non-organic erectile dysfunction refractory to sildenafil monotherapy

Abstract

The purpose of this work was to investigate the efficacy and safety of sildenafil in combination with doxazosin for the treatment of non-organic erectile dysfunction in patients who did not respond to sildenafil. We enrolled 28 patients with non-organic erectile dysfunction, for whom 3 months of sildenafil monotherapy had failed. They were divided in two random and homogeneous groups: 14 were treated with doxazosin (4 mg daily) and sildenafil (100 mg 1 h before sexual intercourse); the other 14 patients received sildenafil and placebo. The results were assessed by means of the IIEF questionnaire before the beginning of the study, after 30 days of therapy and after 60 days. Of the 14 patients treated with doxazosin and sildenafil, 11 (78.6%) showed a statistically significant increase of IIEF; in the placebo group, only one patient (7.1%) recorded a significant IIEF increase. The differences observed in the two groups were statistically very significant (P=0.0016). Blood pressure did not show significant alterations. Side effects were minimal and even present during sildenafil monotherapy. The combination therapy with sildenafil and doxazosin resulted in the safe and effective treatment of men with non-organic erectile dysfunction for whom sildenafil alone had failed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. NIH Consensus Development Panel on Impotence. . NIH Consensus Conference. JAMA 1993 270: 83–90.

    Article  Google Scholar 

  2. Krane RJ. . Changes in ED therapy in the Viagra era. World J Urol 2001 19: 23–24.

    Article  CAS  Google Scholar 

  3. Padma-Nathan H, Steers WD, Wicker PA. . Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998 52: 375–379.

    CAS  PubMed  Google Scholar 

  4. Goldstein I et al . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Engl J Med 1998 338: 1397–1404.

    Article  CAS  Google Scholar 

  5. Diederichs W et al . The sympathetic role as antagonist of erection. Urol Res 1991 19: 123–126.

    Article  CAS  Google Scholar 

  6. Andersson KE, Hedlund P, Alm P. . Sympathetic pathways and adrenergic innervation of the penis. Int J Impot Res 2000 12: Suppl 1 5–12.

    Article  Google Scholar 

  7. Traish A, Kim NN, Moreland RB, Goldstein I. . Role of alpha adrenergic receptors in erectile function. Int J Impot Res 2000 12: Suppl 1 48–63.

    Article  Google Scholar 

  8. Bechara A et al . Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction. J Urol 1997 157: 2132–2134.

    Article  CAS  Google Scholar 

  9. Zorgniotti AW. . Experience with buccal phentolamine mesylate for impotence. Int J Impot Res 1994 6: 37–41.

    CAS  PubMed  Google Scholar 

  10. Becker AJ et al . Oral phentolamine as treatment for erectile dysfunction. J Urol 1998 159: 1214–1216.

    Article  CAS  Google Scholar 

  11. Goldstein I. . Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int J Impot Res 2000 12: Suppl 1 75–80.

    Article  Google Scholar 

  12. Kaplan SA et al . Combination therapy using alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998 52: 739–743.

    Article  CAS  Google Scholar 

  13. Rosen RC et al . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 47: 822–830.

    Article  Google Scholar 

  14. Metro M, Broderick G. . The penile blood flow characteristics of Viagra failures. Int J Impot Res 2000 12: Suppl 3 78.

    Google Scholar 

  15. Padma-Nathan H et al . Efficacy and safety of alprostadil (Caverject) in sildenafil (Viagra) failures. J Urol 2000 163: Suppl 201–202.

    Google Scholar 

  16. Rosen RC. . Management of complicated and treatment refractory ED: clinical issues and guidelines. Int J Impot Res 2000 12: Suppl 3 59–60.

    Google Scholar 

  17. Padma-Nathan H. . The efficay and synergy of polypharmacotherapy in primary and salvage therapy of vasculogenic erectile dysfunction. Int J Impot Res 1990 2: 257–258.

    Google Scholar 

  18. Dula E et al . Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group. Urology 2000 56: 130–135.

    Article  CAS  Google Scholar 

  19. Heaton JP. . Apomorphine: an update of clinical trial results. Int J Impot Res 2000 12: Suppl 4 67–73.

    Article  Google Scholar 

  20. Vogt HJ et al . Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res 1997 9: 155–161.

    Article  CAS  Google Scholar 

  21. Klotz T et al . Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World J Urol 2001 19: 32–39.

    Article  CAS  Google Scholar 

  22. Mydlo JH, Volpe MA, Macchia RJ. . Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol 2000 38: 30–34.

    Article  CAS  Google Scholar 

  23. Nehra A et al . Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring non-invasive therapy: 18 month follow-up. J Urol 2000 163, (Suppl): 199.

    Google Scholar 

  24. Grimm RH Jr et al . Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997 29: 8–14.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A F De Rose.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Rose, A., Giglio, M., Traverso, P. et al. Combined oral therapy with sildenafil and doxazosin for the treament of non-organic erectile dysfunction refractory to sildenafil monotherapy. Int J Impot Res 14, 50–53 (2002). https://doi.org/10.1038/sj.ijir.3900815

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900815

Keywords

This article is cited by

Search

Quick links